Clinical Trials Browser

Expanded_access × Leukemia × midostaurin × Clear all

NCT03114228 2019-10-15

An Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML)

No longer available

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute